Human Cardiac Myocytes Search Results


95
PromoCell human cardiac myocytes
Human Cardiac Myocytes, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Cardiac+Myocytes/Human+Cardiac+Myocytes/med_rxiv__2025__10__09__25337646-231-0-3
Average 95 stars, based on 1 article reviews
human cardiac myocytes - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

91
Innoprot Inc cardiomyocytes
Antibody validation. (A) Upper images show the result of a western blot analysis of human Kir6.2 in five specimens of human brain tissue (lanes 1 to 5: 2, 4 corresponding to contusion specimens and 1, 3, 5 corresponding to healthy tissue) using two independent antibodies (Alomone Ab and GeneTex Ab). The bar graphs are shown as a visual aid for the inmunoblot results. Optical density with both antibodies was compared and resulted in a Pearson correlation coefficient of 0.88 (p = 0.049). The scatterplot is shown as a visual aid to the immunoblot results. (B) Fluorescence labeling of Kir6.2 using Alomone Ab (red) and SantaCruz Ab (green); merged images in yellow. (C) Western blot analysis of a human recombinant Kir6.2 protein (ab114436; Abcam, Cambridge, UK) (1) tagged with green fluorescent protein (GFP) and GFP recombinant protein (2) used as a negative control. (D) Kir6.2 expression (green) in a cell line of human <t>cardiomyocytes</t> <t>(P10451;</t> Innoprot, Derio, Spain) used as a positive control. Nuclei were counterstained with 4,6-diamino-2-phenylindole (DAPI).
Cardiomyocytes, supplied by Innoprot Inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Cardiac+Myocytes/Human+Cardiac+Myocytes/pmc07872003-142-70-75
Average 91 stars, based on 1 article reviews
cardiomyocytes - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

93
Axol Bioscience human ipsc derived cardiomyocytes
Antibody validation. (A) Upper images show the result of a western blot analysis of human Kir6.2 in five specimens of human brain tissue (lanes 1 to 5: 2, 4 corresponding to contusion specimens and 1, 3, 5 corresponding to healthy tissue) using two independent antibodies (Alomone Ab and GeneTex Ab). The bar graphs are shown as a visual aid for the inmunoblot results. Optical density with both antibodies was compared and resulted in a Pearson correlation coefficient of 0.88 (p = 0.049). The scatterplot is shown as a visual aid to the immunoblot results. (B) Fluorescence labeling of Kir6.2 using Alomone Ab (red) and SantaCruz Ab (green); merged images in yellow. (C) Western blot analysis of a human recombinant Kir6.2 protein (ab114436; Abcam, Cambridge, UK) (1) tagged with green fluorescent protein (GFP) and GFP recombinant protein (2) used as a negative control. (D) Kir6.2 expression (green) in a cell line of human <t>cardiomyocytes</t> <t>(P10451;</t> Innoprot, Derio, Spain) used as a positive control. Nuclei were counterstained with 4,6-diamino-2-phenylindole (DAPI).
Human Ipsc Derived Cardiomyocytes, supplied by Axol Bioscience, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Cardiac+Myocytes/Human+iPSC-Derived+Ventricular+Cardiomyocytes/pmc07723245-131-0-11
Average 93 stars, based on 1 article reviews
human ipsc derived cardiomyocytes - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
PromoCell cell lines cell line source s human cardiac myocyte cells
Antibody validation. (A) Upper images show the result of a western blot analysis of human Kir6.2 in five specimens of human brain tissue (lanes 1 to 5: 2, 4 corresponding to contusion specimens and 1, 3, 5 corresponding to healthy tissue) using two independent antibodies (Alomone Ab and GeneTex Ab). The bar graphs are shown as a visual aid for the inmunoblot results. Optical density with both antibodies was compared and resulted in a Pearson correlation coefficient of 0.88 (p = 0.049). The scatterplot is shown as a visual aid to the immunoblot results. (B) Fluorescence labeling of Kir6.2 using Alomone Ab (red) and SantaCruz Ab (green); merged images in yellow. (C) Western blot analysis of a human recombinant Kir6.2 protein (ab114436; Abcam, Cambridge, UK) (1) tagged with green fluorescent protein (GFP) and GFP recombinant protein (2) used as a negative control. (D) Kir6.2 expression (green) in a cell line of human <t>cardiomyocytes</t> <t>(P10451;</t> Innoprot, Derio, Spain) used as a positive control. Nuclei were counterstained with 4,6-diamino-2-phenylindole (DAPI).
Cell Lines Cell Line Source S Human Cardiac Myocyte Cells, supplied by PromoCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Cardiac+Myocytes/Cell+KIT+-+Human+Cardiac+Myocyte/pmc08140137__41525_2021_199_MOESM2_ESM-20-47-59
Average 90 stars, based on 1 article reviews
cell lines cell line source s human cardiac myocyte cells - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

91
PromoCell rnalater
Antibody validation. (A) Upper images show the result of a western blot analysis of human Kir6.2 in five specimens of human brain tissue (lanes 1 to 5: 2, 4 corresponding to contusion specimens and 1, 3, 5 corresponding to healthy tissue) using two independent antibodies (Alomone Ab and GeneTex Ab). The bar graphs are shown as a visual aid for the inmunoblot results. Optical density with both antibodies was compared and resulted in a Pearson correlation coefficient of 0.88 (p = 0.049). The scatterplot is shown as a visual aid to the immunoblot results. (B) Fluorescence labeling of Kir6.2 using Alomone Ab (red) and SantaCruz Ab (green); merged images in yellow. (C) Western blot analysis of a human recombinant Kir6.2 protein (ab114436; Abcam, Cambridge, UK) (1) tagged with green fluorescent protein (GFP) and GFP recombinant protein (2) used as a negative control. (D) Kir6.2 expression (green) in a cell line of human <t>cardiomyocytes</t> <t>(P10451;</t> Innoprot, Derio, Spain) used as a positive control. Nuclei were counterstained with 4,6-diamino-2-phenylindole (DAPI).
Rnalater, supplied by PromoCell, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Cardiac+Myocytes/Human+Cardiac+Myocytes+(HCM)%2C+Cell+Pellet+in+RNAlater/pm37762009-114-7-14
Average 91 stars, based on 1 article reviews
rnalater - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

91
PromoCell human primary cardiac cells
a Six-week-old C57BL/6 mice were inoculated with 1E5 PFU of CHIKV or mock-infected as specified in each panel. Subcutaneous: CHIKV-infected (n = 11) and mock-infected (n = 5). Intravenous: CHIKV-infected (n = 11) and mock-infected (n = 8). Mosquito bite CHIKV-infected (n = 11) and mock-infected (n = 9). b Ratio of E1 viral RNA to nsp4 viral RNA. Dotted line indicates the E1 RNA:nsp4 RNA ratio (R) of 1. Subcutaneous: 2 dpi (n = 4), 5 dpi (n = 8) and 10 dpi (n = 4). Intravenous: 2 dpi (n = 6), 5 dpi (n = 6) and 10 dpi (n = 4). HI-control: 2 dpi (n = 3), 5 dpi (n = 6) and 10 dpi (n = 4). c Representative images from 2 independent experiments showing infected myocardium (scale= 20 μm) and, aortic valve, left atria, and vessels (scale= 30 μm). White arrows: CHIKV-infected <t>cells.</t> d Mice were infected with 1E5 PFU of CHIKV or HI virus intravenously. Left panel: CHIKV RNA levels for top and bottom hearts. Right panel: ratio of viral RNA levels between top and bottom heart sections. For 2 dpi n = 5, for 5 dpi n = 5, for 10 dpi n = 3. Gray box represents background RNA levels quantified for HI control at 5 dpi (n = 1). e Representative fluorescence microscopy images from 3 independent experiments of ventricular sections of CHIKV-infected hearts stained with different <t>cardiac</t> cell type markers. Scale= 15 μm. f Colocalization analysis between CHIKV-infected cells and different cell type markers. Data are represented as the percentage of the total green signal (infected cells) overlapping with the indicated markers. Colocalization analysis was done in 3-4 independent fields for n = 3 mice. g CHIKV multi-cycle growth curves in <t>human</t> <t>primary</t> cardiac cells. n = 2 independent experiments in technical duplicates. Data are represented as mean ± standard error of the mean (SEM, a, b, d, f, g) . p values were calculated using two-tailed Mann-Whitney test ( a, b ), or Kruskal–Wallis and Dunn’s multiple comparison test (d, f) . Created with BioRender.com. Source data are provided as a source data file.
Human Primary Cardiac Cells, supplied by PromoCell, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Cardiac+Myocytes/Cell+KIT+-+Human+Cardiac+Myocyte+Plus/pmc10400619-326-0-7
Average 91 stars, based on 1 article reviews
human primary cardiac cells - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

90
ScienCell fetal human cardiac myocytes (hcm) catalog number 6200
a Six-week-old C57BL/6 mice were inoculated with 1E5 PFU of CHIKV or mock-infected as specified in each panel. Subcutaneous: CHIKV-infected (n = 11) and mock-infected (n = 5). Intravenous: CHIKV-infected (n = 11) and mock-infected (n = 8). Mosquito bite CHIKV-infected (n = 11) and mock-infected (n = 9). b Ratio of E1 viral RNA to nsp4 viral RNA. Dotted line indicates the E1 RNA:nsp4 RNA ratio (R) of 1. Subcutaneous: 2 dpi (n = 4), 5 dpi (n = 8) and 10 dpi (n = 4). Intravenous: 2 dpi (n = 6), 5 dpi (n = 6) and 10 dpi (n = 4). HI-control: 2 dpi (n = 3), 5 dpi (n = 6) and 10 dpi (n = 4). c Representative images from 2 independent experiments showing infected myocardium (scale= 20 μm) and, aortic valve, left atria, and vessels (scale= 30 μm). White arrows: CHIKV-infected <t>cells.</t> d Mice were infected with 1E5 PFU of CHIKV or HI virus intravenously. Left panel: CHIKV RNA levels for top and bottom hearts. Right panel: ratio of viral RNA levels between top and bottom heart sections. For 2 dpi n = 5, for 5 dpi n = 5, for 10 dpi n = 3. Gray box represents background RNA levels quantified for HI control at 5 dpi (n = 1). e Representative fluorescence microscopy images from 3 independent experiments of ventricular sections of CHIKV-infected hearts stained with different <t>cardiac</t> cell type markers. Scale= 15 μm. f Colocalization analysis between CHIKV-infected cells and different cell type markers. Data are represented as the percentage of the total green signal (infected cells) overlapping with the indicated markers. Colocalization analysis was done in 3-4 independent fields for n = 3 mice. g CHIKV multi-cycle growth curves in <t>human</t> <t>primary</t> cardiac cells. n = 2 independent experiments in technical duplicates. Data are represented as mean ± standard error of the mean (SEM, a, b, d, f, g) . p values were calculated using two-tailed Mann-Whitney test ( a, b ), or Kruskal–Wallis and Dunn’s multiple comparison test (d, f) . Created with BioRender.com. Source data are provided as a source data file.
Fetal Human Cardiac Myocytes (Hcm) Catalog Number 6200, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Cardiac+Myocytes/fetal+human+cardiac+myocytes/pmc04436519-40-0-21
Average 90 stars, based on 1 article reviews
fetal human cardiac myocytes (hcm) catalog number 6200 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
ScienCell human cardiac myocytes catalog no. 6200
a Six-week-old C57BL/6 mice were inoculated with 1E5 PFU of CHIKV or mock-infected as specified in each panel. Subcutaneous: CHIKV-infected (n = 11) and mock-infected (n = 5). Intravenous: CHIKV-infected (n = 11) and mock-infected (n = 8). Mosquito bite CHIKV-infected (n = 11) and mock-infected (n = 9). b Ratio of E1 viral RNA to nsp4 viral RNA. Dotted line indicates the E1 RNA:nsp4 RNA ratio (R) of 1. Subcutaneous: 2 dpi (n = 4), 5 dpi (n = 8) and 10 dpi (n = 4). Intravenous: 2 dpi (n = 6), 5 dpi (n = 6) and 10 dpi (n = 4). HI-control: 2 dpi (n = 3), 5 dpi (n = 6) and 10 dpi (n = 4). c Representative images from 2 independent experiments showing infected myocardium (scale= 20 μm) and, aortic valve, left atria, and vessels (scale= 30 μm). White arrows: CHIKV-infected <t>cells.</t> d Mice were infected with 1E5 PFU of CHIKV or HI virus intravenously. Left panel: CHIKV RNA levels for top and bottom hearts. Right panel: ratio of viral RNA levels between top and bottom heart sections. For 2 dpi n = 5, for 5 dpi n = 5, for 10 dpi n = 3. Gray box represents background RNA levels quantified for HI control at 5 dpi (n = 1). e Representative fluorescence microscopy images from 3 independent experiments of ventricular sections of CHIKV-infected hearts stained with different <t>cardiac</t> cell type markers. Scale= 15 μm. f Colocalization analysis between CHIKV-infected cells and different cell type markers. Data are represented as the percentage of the total green signal (infected cells) overlapping with the indicated markers. Colocalization analysis was done in 3-4 independent fields for n = 3 mice. g CHIKV multi-cycle growth curves in <t>human</t> <t>primary</t> cardiac cells. n = 2 independent experiments in technical duplicates. Data are represented as mean ± standard error of the mean (SEM, a, b, d, f, g) . p values were calculated using two-tailed Mann-Whitney test ( a, b ), or Kruskal–Wallis and Dunn’s multiple comparison test (d, f) . Created with BioRender.com. Source data are provided as a source data file.
Human Cardiac Myocytes Catalog No. 6200, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Cardiac+Myocytes/human+cardiac+myocytes+catalog+no++6200/10__1097_slash_aln__0000000000003037-38-0-9
Average 90 stars, based on 1 article reviews
human cardiac myocytes catalog no. 6200 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
CellSystems Biotechnologie Vertrieb GmbH primary human ventricular cardiac myocytes
(a) Hearts obtained from untreated control animals evidenced an extensive scar size and signs of <t>ventricular</t> dilation, whereas scar size was reduced in ATG injected rats with a better preserved ventricular geometry (b). ATG injection after AMI resulted in a reduction of scar size from 24.95% of the left ventricle in untreated controls to 11.43% in the treatment group, p<0.01, n = 9–13 per group). Parameters of cardiac function (ejection fraction, shortening fraction, left ventricular end-diastolic diameter and left ventricular end-systolic diameter) were significantly improved by ATG (d,e,f,g).
Primary Human Ventricular Cardiac Myocytes, supplied by CellSystems Biotechnologie Vertrieb GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Cardiac+Myocytes/primary+human+ventricular+cardiac+myocytes/pmc03527351-93-0-8
Average 90 stars, based on 1 article reviews
primary human ventricular cardiac myocytes - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
ScienCell human cardiac myocytes media
(a) Hearts obtained from untreated control animals evidenced an extensive scar size and signs of <t>ventricular</t> dilation, whereas scar size was reduced in ATG injected rats with a better preserved ventricular geometry (b). ATG injection after AMI resulted in a reduction of scar size from 24.95% of the left ventricle in untreated controls to 11.43% in the treatment group, p<0.01, n = 9–13 per group). Parameters of cardiac function (ejection fraction, shortening fraction, left ventricular end-diastolic diameter and left ventricular end-systolic diameter) were significantly improved by ATG (d,e,f,g).
Human Cardiac Myocytes Media, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Cardiac+Myocytes/human+cardiac+myocytes+media/pm29464058-154-5-8
Average 90 stars, based on 1 article reviews
human cardiac myocytes media - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Merck KGaA human cardiac myocyte cell line scc109
(a) Hearts obtained from untreated control animals evidenced an extensive scar size and signs of <t>ventricular</t> dilation, whereas scar size was reduced in ATG injected rats with a better preserved ventricular geometry (b). ATG injection after AMI resulted in a reduction of scar size from 24.95% of the left ventricle in untreated controls to 11.43% in the treatment group, p<0.01, n = 9–13 per group). Parameters of cardiac function (ejection fraction, shortening fraction, left ventricular end-diastolic diameter and left ventricular end-systolic diameter) were significantly improved by ATG (d,e,f,g).
Human Cardiac Myocyte Cell Line Scc109, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Cardiac+Myocytes/human+cardiac+myocyte+cell+line+scc109/pmc10915973-182-2-11
Average 90 stars, based on 1 article reviews
human cardiac myocyte cell line scc109 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
3H Biomedical human cardiac myocyte cdna library sc6204
(a) Hearts obtained from untreated control animals evidenced an extensive scar size and signs of <t>ventricular</t> dilation, whereas scar size was reduced in ATG injected rats with a better preserved ventricular geometry (b). ATG injection after AMI resulted in a reduction of scar size from 24.95% of the left ventricle in untreated controls to 11.43% in the treatment group, p<0.01, n = 9–13 per group). Parameters of cardiac function (ejection fraction, shortening fraction, left ventricular end-diastolic diameter and left ventricular end-systolic diameter) were significantly improved by ATG (d,e,f,g).
Human Cardiac Myocyte Cdna Library Sc6204, supplied by 3H Biomedical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Cardiac+Myocytes/human+cardiac+myocyte+cdna+library+sc6204/pm27076034-64-11-18
Average 90 stars, based on 1 article reviews
human cardiac myocyte cdna library sc6204 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Antibody validation. (A) Upper images show the result of a western blot analysis of human Kir6.2 in five specimens of human brain tissue (lanes 1 to 5: 2, 4 corresponding to contusion specimens and 1, 3, 5 corresponding to healthy tissue) using two independent antibodies (Alomone Ab and GeneTex Ab). The bar graphs are shown as a visual aid for the inmunoblot results. Optical density with both antibodies was compared and resulted in a Pearson correlation coefficient of 0.88 (p = 0.049). The scatterplot is shown as a visual aid to the immunoblot results. (B) Fluorescence labeling of Kir6.2 using Alomone Ab (red) and SantaCruz Ab (green); merged images in yellow. (C) Western blot analysis of a human recombinant Kir6.2 protein (ab114436; Abcam, Cambridge, UK) (1) tagged with green fluorescent protein (GFP) and GFP recombinant protein (2) used as a negative control. (D) Kir6.2 expression (green) in a cell line of human cardiomyocytes (P10451; Innoprot, Derio, Spain) used as a positive control. Nuclei were counterstained with 4,6-diamino-2-phenylindole (DAPI).

Journal: Journal of Neurotrauma

Article Title: Kir6.2, the Pore-Forming Subunit of ATP-Sensitive K + Channels, Is Overexpressed in Human Posttraumatic Brain Contusions

doi: 10.1089/neu.2017.5619

Figure Lengend Snippet: Antibody validation. (A) Upper images show the result of a western blot analysis of human Kir6.2 in five specimens of human brain tissue (lanes 1 to 5: 2, 4 corresponding to contusion specimens and 1, 3, 5 corresponding to healthy tissue) using two independent antibodies (Alomone Ab and GeneTex Ab). The bar graphs are shown as a visual aid for the inmunoblot results. Optical density with both antibodies was compared and resulted in a Pearson correlation coefficient of 0.88 (p = 0.049). The scatterplot is shown as a visual aid to the immunoblot results. (B) Fluorescence labeling of Kir6.2 using Alomone Ab (red) and SantaCruz Ab (green); merged images in yellow. (C) Western blot analysis of a human recombinant Kir6.2 protein (ab114436; Abcam, Cambridge, UK) (1) tagged with green fluorescent protein (GFP) and GFP recombinant protein (2) used as a negative control. (D) Kir6.2 expression (green) in a cell line of human cardiomyocytes (P10451; Innoprot, Derio, Spain) used as a positive control. Nuclei were counterstained with 4,6-diamino-2-phenylindole (DAPI).

Article Snippet: The scatterplot is shown as a visual aid to the immunoblot results. (B) Fluorescence labeling of Kir6.2 using Alomone Ab (red) and SantaCruz Ab (green); merged images in yellow. (C) Western blot analysis of a human recombinant Kir6.2 protein (ab114436; Abcam, Cambridge, UK) (1) tagged with green fluorescent protein (GFP) and GFP recombinant protein (2) used as a negative control. (D) Kir6.2 expression (green) in a cell line of human cardiomyocytes ( {"type":"entrez-protein","attrs":{"text":"P10451","term_id":"129260","term_text":"P10451"}} P10451 ; Innoprot, Derio, Spain) used as a positive control.

Techniques: Biomarker Discovery, Western Blot, Fluorescence, Labeling, Recombinant, Negative Control, Expressing, Positive Control

a Six-week-old C57BL/6 mice were inoculated with 1E5 PFU of CHIKV or mock-infected as specified in each panel. Subcutaneous: CHIKV-infected (n = 11) and mock-infected (n = 5). Intravenous: CHIKV-infected (n = 11) and mock-infected (n = 8). Mosquito bite CHIKV-infected (n = 11) and mock-infected (n = 9). b Ratio of E1 viral RNA to nsp4 viral RNA. Dotted line indicates the E1 RNA:nsp4 RNA ratio (R) of 1. Subcutaneous: 2 dpi (n = 4), 5 dpi (n = 8) and 10 dpi (n = 4). Intravenous: 2 dpi (n = 6), 5 dpi (n = 6) and 10 dpi (n = 4). HI-control: 2 dpi (n = 3), 5 dpi (n = 6) and 10 dpi (n = 4). c Representative images from 2 independent experiments showing infected myocardium (scale= 20 μm) and, aortic valve, left atria, and vessels (scale= 30 μm). White arrows: CHIKV-infected cells. d Mice were infected with 1E5 PFU of CHIKV or HI virus intravenously. Left panel: CHIKV RNA levels for top and bottom hearts. Right panel: ratio of viral RNA levels between top and bottom heart sections. For 2 dpi n = 5, for 5 dpi n = 5, for 10 dpi n = 3. Gray box represents background RNA levels quantified for HI control at 5 dpi (n = 1). e Representative fluorescence microscopy images from 3 independent experiments of ventricular sections of CHIKV-infected hearts stained with different cardiac cell type markers. Scale= 15 μm. f Colocalization analysis between CHIKV-infected cells and different cell type markers. Data are represented as the percentage of the total green signal (infected cells) overlapping with the indicated markers. Colocalization analysis was done in 3-4 independent fields for n = 3 mice. g CHIKV multi-cycle growth curves in human primary cardiac cells. n = 2 independent experiments in technical duplicates. Data are represented as mean ± standard error of the mean (SEM, a, b, d, f, g) . p values were calculated using two-tailed Mann-Whitney test ( a, b ), or Kruskal–Wallis and Dunn’s multiple comparison test (d, f) . Created with BioRender.com. Source data are provided as a source data file.

Journal: Nature Communications

Article Title: MAVS signaling is required for preventing persistent chikungunya heart infection and chronic vascular tissue inflammation

doi: 10.1038/s41467-023-40047-w

Figure Lengend Snippet: a Six-week-old C57BL/6 mice were inoculated with 1E5 PFU of CHIKV or mock-infected as specified in each panel. Subcutaneous: CHIKV-infected (n = 11) and mock-infected (n = 5). Intravenous: CHIKV-infected (n = 11) and mock-infected (n = 8). Mosquito bite CHIKV-infected (n = 11) and mock-infected (n = 9). b Ratio of E1 viral RNA to nsp4 viral RNA. Dotted line indicates the E1 RNA:nsp4 RNA ratio (R) of 1. Subcutaneous: 2 dpi (n = 4), 5 dpi (n = 8) and 10 dpi (n = 4). Intravenous: 2 dpi (n = 6), 5 dpi (n = 6) and 10 dpi (n = 4). HI-control: 2 dpi (n = 3), 5 dpi (n = 6) and 10 dpi (n = 4). c Representative images from 2 independent experiments showing infected myocardium (scale= 20 μm) and, aortic valve, left atria, and vessels (scale= 30 μm). White arrows: CHIKV-infected cells. d Mice were infected with 1E5 PFU of CHIKV or HI virus intravenously. Left panel: CHIKV RNA levels for top and bottom hearts. Right panel: ratio of viral RNA levels between top and bottom heart sections. For 2 dpi n = 5, for 5 dpi n = 5, for 10 dpi n = 3. Gray box represents background RNA levels quantified for HI control at 5 dpi (n = 1). e Representative fluorescence microscopy images from 3 independent experiments of ventricular sections of CHIKV-infected hearts stained with different cardiac cell type markers. Scale= 15 μm. f Colocalization analysis between CHIKV-infected cells and different cell type markers. Data are represented as the percentage of the total green signal (infected cells) overlapping with the indicated markers. Colocalization analysis was done in 3-4 independent fields for n = 3 mice. g CHIKV multi-cycle growth curves in human primary cardiac cells. n = 2 independent experiments in technical duplicates. Data are represented as mean ± standard error of the mean (SEM, a, b, d, f, g) . p values were calculated using two-tailed Mann-Whitney test ( a, b ), or Kruskal–Wallis and Dunn’s multiple comparison test (d, f) . Created with BioRender.com. Source data are provided as a source data file.

Article Snippet: Human primary cardiac cells were obtained from PromoCell, used up to passage 10, and grown following the company recommendations.

Techniques: Infection, Control, Virus, Fluorescence, Microscopy, Staining, Two Tailed Test, MANN-WHITNEY, Comparison

a Heat map showing the differentially expressed genes (FDR < 0.15) from the Hallmark IFNα response pathway for CHIKV-infected and HI-control hearts. b Top panel: representative fluorescence microscopy images from two independent repetitions showing ventricular sections of CHIKV-infected hearts and PBS control stained with anti-ISG15 and anti-vimentin antibodies. Scale= 10 μm. Bottom panel: Quantification of ISG15 + signal/field. Analysis was done on two independent fields for PBS control (n = 2), and CHIKV-infected (n = 6). c Dependence on IFN-I signaling in human primary cardiac fibroblasts during CHIKV infection. Cells were pretreated as indicated in the figure and infected with CHIKV-ZsGreen at an MOI of 0.25. Data represent three independent repetitions in technical duplicates. d IFN-I pretreatment experiments in human primary cardiac cell types. Cells were pretreated with different concentrations of recombinant IFN-α (right panel) and IFN-β (left panel) for 24 h and then infected with CHIKV-ZsGreen at an MOI of 0.25 for 24 h. For IFN-α: three independent repetitions in technical duplicates. For IFN-β: four independent repetitions in technical duplicates. e Representative fluorescence microscopy images from three independent repetitions showing CHIKV-ZsGreen WT or Ifnar1 −/− infected hearts at 1 dpi. Scale= 30 μm. f Percentage of the total of infected cells (green signal) overlapping with the indicated makers (See Supplementary Fig. ). Colocalization analysis was done in three to five independent sections for n = 2 mice. g Left panel: Apoptosis staining was measured by IHC against cleaved CASP3. Scale= 50 μm. Arrows highlight apoptotic foci. Right panel: Quantifications of cleaved CASP3 nuclei versus total nuclei were performed in whole ventricular sections (LV, RV, and septum) using Visiopharm R . Each dot represents one individual mouse. PBS control (n = 5), CHIKV-infected WT (n = 5), and CHIKV-infected Ifnar1 −/− mice (n = 6). Data are represented as mean ± SEM ( b – d , f , g) . P values were calculated using two-tailed Mann–Whitney ( b ), or one-way ANOVA with Dunnett’s multiple comparison test ( c , d , g) , or Kruskal–Wallis with Dunn’s multiple comparison test ( f ). Created with BioRender.com. Source data are provided as a source data file.

Journal: Nature Communications

Article Title: MAVS signaling is required for preventing persistent chikungunya heart infection and chronic vascular tissue inflammation

doi: 10.1038/s41467-023-40047-w

Figure Lengend Snippet: a Heat map showing the differentially expressed genes (FDR < 0.15) from the Hallmark IFNα response pathway for CHIKV-infected and HI-control hearts. b Top panel: representative fluorescence microscopy images from two independent repetitions showing ventricular sections of CHIKV-infected hearts and PBS control stained with anti-ISG15 and anti-vimentin antibodies. Scale= 10 μm. Bottom panel: Quantification of ISG15 + signal/field. Analysis was done on two independent fields for PBS control (n = 2), and CHIKV-infected (n = 6). c Dependence on IFN-I signaling in human primary cardiac fibroblasts during CHIKV infection. Cells were pretreated as indicated in the figure and infected with CHIKV-ZsGreen at an MOI of 0.25. Data represent three independent repetitions in technical duplicates. d IFN-I pretreatment experiments in human primary cardiac cell types. Cells were pretreated with different concentrations of recombinant IFN-α (right panel) and IFN-β (left panel) for 24 h and then infected with CHIKV-ZsGreen at an MOI of 0.25 for 24 h. For IFN-α: three independent repetitions in technical duplicates. For IFN-β: four independent repetitions in technical duplicates. e Representative fluorescence microscopy images from three independent repetitions showing CHIKV-ZsGreen WT or Ifnar1 −/− infected hearts at 1 dpi. Scale= 30 μm. f Percentage of the total of infected cells (green signal) overlapping with the indicated makers (See Supplementary Fig. ). Colocalization analysis was done in three to five independent sections for n = 2 mice. g Left panel: Apoptosis staining was measured by IHC against cleaved CASP3. Scale= 50 μm. Arrows highlight apoptotic foci. Right panel: Quantifications of cleaved CASP3 nuclei versus total nuclei were performed in whole ventricular sections (LV, RV, and septum) using Visiopharm R . Each dot represents one individual mouse. PBS control (n = 5), CHIKV-infected WT (n = 5), and CHIKV-infected Ifnar1 −/− mice (n = 6). Data are represented as mean ± SEM ( b – d , f , g) . P values were calculated using two-tailed Mann–Whitney ( b ), or one-way ANOVA with Dunnett’s multiple comparison test ( c , d , g) , or Kruskal–Wallis with Dunn’s multiple comparison test ( f ). Created with BioRender.com. Source data are provided as a source data file.

Article Snippet: Human primary cardiac cells were obtained from PromoCell, used up to passage 10, and grown following the company recommendations.

Techniques: Infection, Control, Fluorescence, Microscopy, Staining, Recombinant, Two Tailed Test, MANN-WHITNEY, Comparison

(a) Hearts obtained from untreated control animals evidenced an extensive scar size and signs of ventricular dilation, whereas scar size was reduced in ATG injected rats with a better preserved ventricular geometry (b). ATG injection after AMI resulted in a reduction of scar size from 24.95% of the left ventricle in untreated controls to 11.43% in the treatment group, p<0.01, n = 9–13 per group). Parameters of cardiac function (ejection fraction, shortening fraction, left ventricular end-diastolic diameter and left ventricular end-systolic diameter) were significantly improved by ATG (d,e,f,g).

Journal: PLoS ONE

Article Title: Anti-Thymocyte Globulin Induces Neoangiogenesis and Preserves Cardiac Function after Experimental Myocardial Infarction

doi: 10.1371/journal.pone.0052101

Figure Lengend Snippet: (a) Hearts obtained from untreated control animals evidenced an extensive scar size and signs of ventricular dilation, whereas scar size was reduced in ATG injected rats with a better preserved ventricular geometry (b). ATG injection after AMI resulted in a reduction of scar size from 24.95% of the left ventricle in untreated controls to 11.43% in the treatment group, p<0.01, n = 9–13 per group). Parameters of cardiac function (ejection fraction, shortening fraction, left ventricular end-diastolic diameter and left ventricular end-systolic diameter) were significantly improved by ATG (d,e,f,g).

Article Snippet: Primary human ventricular cardiac myocytes were obtained from CellSystems (CellSystems Biotechnologie, St. Katharinen, Germany) and were cultured in cardiac myocyte medium (CellSystems) at 37°C at a cell density of 3*10 5 in 6-well plates for 24 hours.

Techniques: Control, Injection